We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+1.43%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$10.8B
AUM Growth
-$261M
Cap. Flow
-$202M
Cap. Flow %
-1.87%
Top 10 Hldgs %
9.55%
Holding
1,226
New
73
Increased
457
Reduced
388
Closed
76

Top Buys

Rank Stock Value
1
VIRT icon
Virtu Financial
VIRT
+$33.4M
2
MLAB icon
Mesa Laboratories
MLAB
+$27.4M
3
TNC icon
Tennant Co
TNC
+$19.8M
4
KWR icon
Quaker Houghton
KWR
+$18.2M
5
HLI icon
Houlihan Lokey
HLI
+$17.9M

Sector Composition

Rank Sector Weight
1 Industrials 28.27%
2 Technology 17.79%
3 Financials 14.2%
4 Consumer Discretionary 12.75%
5 Materials 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LFVN icon
1101
LifeVantage
LFVN
$78.3M
$28K ﹤0.01%
2,062
+629
+44% +$7.67K
ALEC icon
1102
Alector
ALEC
$247M
$27K ﹤0.01%
1,860
+757
+69% +$13.7K
XELB icon
1103
Xcel Brands
XELB
$5.84M
$27K ﹤0.01%
+1,378
New +$28.1K
GSB
1104
DELISTED
GlobalSCAPE, Inc.
GSB
$27K ﹤0.01%
+2,317
New +$26.8K
STRO icon
1105
Sutro Biopharma
STRO
$280M
$26K ﹤0.01%
+285
New +$28.8K
WINA icon
1106
Winmark
WINA
$1.08B
$26K ﹤0.01%
147
+61
+71% +$10.3K
FONR
1107
DELISTED
Fonar
FONR
$25K ﹤0.01%
1,225
+335
+38% +$7.7K
SIGA icon
1108
SIGA Technologies
SIGA
$226M
$25K ﹤0.01%
4,844
+1,527
+46% +$8.23K
VYGR icon
1109
Voyager Therapeutics
VYGR
$197M
$24K ﹤0.01%
+1,420
New +$29.8K
IRMD icon
1110
iRadimed
IRMD
$1.06B
$23K ﹤0.01%
1,113
+451
+68% +$9.21K
TCMD icon
1111
Tactile Systems Technology
TCMD
$511M
$23K ﹤0.01%
549
-31,775
-98% -$1.64M
PRNB
1112
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$20K ﹤0.01%
719
+187
+35% +$6.86K
PBYI icon
1113
Puma Biotechnology
PBYI
$472M
$19K ﹤0.01%
+1,749
New +$18.9K
RVLT
1114
DELISTED
Revolution Lighting Technologies, Inc. - Class A
RVLT
$19K ﹤0.01%
81,200
CCRD
1115
DELISTED
CoreCard
CCRD
$18K ﹤0.01%
422
-9
-2% -$402
IEAWW
1116
DELISTED
Infrastructure and Energy Alternatives, Inc. Warrant
IEAWW
$3K ﹤0.01%
100,000
ALSN icon
1117
Allison Transmission
ALSN
$10.2B
$2K ﹤0.01%
37
-9,000
-100% -$408K
CW icon
1118
Curtiss-Wright
CW
$20.4B
$2K ﹤0.01%
14
DINO icon
1119
HF Sinclair
DINO
$19B
$2K ﹤0.01%
+29
New +$1.41K
EME icon
1120
Emcor
EME
$33.1B
$2K ﹤0.01%
22
-50,412
-100% -$4.29M
EWBC icon
1121
East-West Bancorp
EWBC
$17.8B
$2K ﹤0.01%
37
FNB icon
1122
FNB Corp
FNB
$6.52B
$2K ﹤0.01%
156
FRME icon
1123
First Merchants
FRME
$2.61B
$2K ﹤0.01%
43
HOPE icon
1124
Hope Bancorp
HOPE
$1.79B
$2K ﹤0.01%
132
IBOC icon
1125
International Bancshares
IBOC
$4.46B
$2K ﹤0.01%
47

Similar funds

Royce & Associates's Q3 2019 Portfolio in Review

As of Q3 2019, Royce & Associates held 1,226 positions worth $10.8B, down 2.4% from $11.1B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Royce & Associates's Q3 2019 filing shows 73 new, 457 increased, 388 reduced and 76 closed positions. Its largest new stake was Upbound Group: 521,616 shares worth $13.5M. The largest sale was John B. Sanfilippo & Son, an estimated $73.8M.

By sector, the portfolio is most concentrated in Industrials at 28% of assets, down from 29% a quarter earlier, followed by Technology and Financials.

  • Royce & Associates's largest Q3 2019 buy was Upbound Group: 521,616 shares worth $13.5M.
  • Royce & Associates added most to Virtu Financial in Q3 2019, an estimated $33.4M increase.
  • Royce & Associates's biggest Q3 2019 reduction was John B. Sanfilippo & Son, cutting an estimated $73.8M.
  • Royce & Associates fully exited Cambrex Corporation in Q3 2019, selling an estimated $14.7M.
  • Royce & Associates's ten largest holdings make up 9.6% of its $10.8B portfolio in Q3 2019.
  • Royce & Associates opened 73 new positions and closed 76 in Q3 2019.
  • Royce & Associates's portfolio value fell 2.4% quarter-over-quarter to $10.8B.

Based on Royce & Associates's 13F filing for Q3 2019, filed 13 Nov 2019.